Verenium says will reach $55M-$60M in revenues for 2011

December 15, 2010 |

In Massachusetts, Verenium announced its 2011 company goals and, for the first time, financial guidance for the upcoming year, projecting that it would reach $55 million to $60 million in revenues and product gross margins of $21 million to $24 million.

The company did not release a net earnings per share target, but it highlighted its 2010 achievements in launching Launched Deltazym Gluco-Amylase enzymes for corn ethanol, and Xylathin for wheat ethanol. The company also touted marketing partnerships with Alfa Laval and Desmet Ballestra to market its Purifine line of enzymes for degumming edible oils.

More on the story.

Print Friendly, PDF & Email

Tags: ,

Category: Producer News

Thank you for visting the Digest.